bet9¹ÙÍø receives final approval for generic Baraclude® tablets

bet9¹ÙÍø completes acquisition of generic businesses in US

bet9¹ÙÍø announces Q3 FY1516 Unaudited Consolidated Financial Results

Big Pharma’s Worst Nightmare

CARE reaffirms ‘CARE AAA / A1+’ rating

Global pharmaceutical industry calls on governments to work with them to beat the rising threat of drug resistance

CARE reaffirms ‘CARE AAA / A1+’ rating

The Medicines Patent Pool Signs First Sub-licences for Hepatitis C Medicine Daclatasvir

bet9¹ÙÍø Announces its Management Council

BioQ Pharma and bet9¹ÙÍø Enter into an Agreement to Commercialize BioQ’s Ropivacaine Infusion System in India

Subscribe to